Cargando…

Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell

Although advances in vascular interventions can reduce the mortality associated with cardiovascular disease, neointimal hyperplasia remains a clinically significant obstacle limiting the success of current interventions. Identification of signaling pathways involved in migration and proliferation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ju Hee, Choung, Sorim, Kim, Ji Min, Lee, Jung Uee, Kim, Koon Soon, Kim, Hyun Jin, Jeong, Jae-Wook, Ku, Bon Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276689/ https://www.ncbi.nlm.nih.gov/pubmed/25574067 http://dx.doi.org/10.1155/2014/549054

Ejemplares similares

Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6
por: Lee, Jun Choul, et al.
Publicado: (2014)

Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia
por: Ko, Dai Sik, et al.
Publicado: (2022)

PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury
por: Yang, Han-Mo, et al.
Publicado: (2013)

Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia
por: Shan, Dan, et al.
Publicado: (2022)

The Role of Circulating Slit2, the One of the Newly Batokines, in Human Diabetes Mellitus
por: Kang, Yea Eun, et al.
Publicado: (2017)

Induction of ferroptosis promotes vascular smooth muscle cell phenotypic switching and aggravates neointimal hyperplasia in mice
por: Zhang, Shunchi, et al.
Publicado: (2022)

Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2018)

Association between IL-1beta and cardiovascular disease risk in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus: a cross-sectional study
por: Joung, Kyong Hye, et al.
Publicado: (2020)

Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats
por: Buglak, Nicholas E., et al.
Publicado: (2018)

Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation
por: Wu, Wen, et al.
Publicado: (2019)

Viscolin Inhibits In Vitro Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia In Vivo
por: Chen, Chin-Chuan, et al.
Publicado: (2016)

Deletion of Smooth Muscle Lethal Giant Larvae 1 Promotes Neointimal Hyperplasia in Mice
por: Zhang, Ya, et al.
Publicado: (2022)

Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice
por: Choung, Sorim, et al.
Publicado: (2019)

Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by K(V)1.3 channel blockers
por: Cheong, Alex, et al.
Publicado: (2011)

Chemerin Stimulates Vascular Smooth Muscle Cell Proliferation and Carotid Neointimal Hyperplasia by Activating Mitogen-Activated Protein Kinase Signaling
por: Xiong, Wei, et al.
Publicado: (2016)

Smooth muscle cell‐specific Tgfbr1 deficiency attenuates neointimal hyperplasia but promotes an undesired vascular phenotype for injured arteries
por: Liao, Mingmei, et al.
Publicado: (2016)

Role of hsa_circ_0000280 in regulating vascular smooth muscle cell function and attenuating neointimal hyperplasia via ELAVL1
por: Wang, Zunzhe, et al.
Publicado: (2022)

Different Responses of Neointimal Cells to Imatinib Mesylate and Rapamycin Compared with Normal Vascular Smooth Muscle Cells
por: Park, Yang Jin, et al.
Publicado: (2014)

Serum MIG6 concentration is increased by cholesterol-lowering treatment in patients with type 2 diabetes mellitus and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia
por: Serrano, Ramon L., et al.
Publicado: (2019)

Adropin inhibits the phenotypic modulation and proliferation of vascular smooth muscle cells during neointimal hyperplasia by activating the AMPK/ACC signaling pathway
por: Wang, Li, et al.
Publicado: (2021)

Fatty Liver and Insulin Resistance in the Liver-Specific Knockout Mice of Mitogen Inducible Gene-6
por: Park, Byung Kil, et al.
Publicado: (2016)

Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus
por: Kim, Ji Min, et al.
Publicado: (2021)

Vanin-1 Pantetheinase Drives Smooth Muscle Cell Activation in Post-Arterial Injury Neointimal Hyperplasia
por: Dammanahalli, K. Jagadeesha, et al.
Publicado: (2012)

Notch Signaling in Endothelial Cells: Is It the Therapeutic Target for Vascular Neointimal Hyperplasia?
por: Tian, Ding-Yuan, et al.
Publicado: (2017)

Wood-Derived Vascular Patches Loaded With Rapamycin Inhibit Neointimal Hyperplasia
por: Xie, Boao, et al.
Publicado: (2022)

Clinical Implications of Using Post-Challenge Plasma Glucose Levels for Early Diagnosis of Type 2 Diabetes Mellitus in Older Individuals
por: Joung, Kyong Hye, et al.
Publicado: (2018)

Effects of Ramiprilat-Coated Stents on Neointimal Hyperplasia, Inflammation, and Arterial Healing in a Porcine Coronary Restenosis Model
por: Hong, Young Joon, et al.
Publicado: (2011)

Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice
por: Kim, Jong-Ho, et al.
Publicado: (2019)

Notoginsenoside R1 inhibits vascular smooth muscle cell proliferation, migration and neointimal hyperplasia through PI3K/Akt signaling
por: Fang, Haihong, et al.
Publicado: (2018)

Bone marrow-derived mesenchymal stem cells inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia after arterial injury in rats
por: Iso, Yoshitaka, et al.
Publicado: (2018)

Mig-6 Plays a Critical Role in the Regulation of Cholesterol Homeostasis and Bile Acid Synthesis
por: Ku, Bon Jeong, et al.
Publicado: (2012)

Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
por: Choung, Sorim, et al.
Publicado: (2018)

Age-related changes in monocytes exacerbate neointimal hyperplasia after vascular injury
por: Martinez, Laisel, et al.
Publicado: (2015)

Semaphorin-3A protects against neointimal hyperplasia after vascular injury
por: Wu, Jie-hong, et al.
Publicado: (2018)

Activation of Protein Kinase G (PKG) Reduces Neointimal Hyperplasia, Inhibits Platelet Aggregation, and Facilitates Re-endothelialization
por: Kim, Ju-Young, et al.
Publicado: (2016)

Mebendazole Reduces Vascular Smooth Muscle Cell Proliferation and Neointimal Formation Following Vascular Injury in Mice
por: Wang, Jintao, et al.
Publicado: (2014)

Lithium Chloride Inhibits Vascular Smooth Muscle Cell Proliferation and Migration and Alleviates Injury-Induced Neointimal Hyperplasia via Induction of PGC-1α
por: Wang, Zhuyao, et al.
Publicado: (2013)

All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
por: Zhang, Jingzhi, et al.
Publicado: (2019)

Jujuboside B Inhibits Neointimal Hyperplasia and Prevents Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration via Activation of AMPK/PPAR-γ Signaling
por: Ji, Zaixiong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tldonp8rmi1mbqmadctbic0299